Finzati - Logo
BDX logo

Becton, Dickinson and Company

BDX • Medical - Instruments & Supplies
$193.80
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$48.79B
Growth
8.0%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 9.32Consistent free cash flow · 5/5Manageable debt level · 0.76Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:16 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$193.80
Change0.00%
Market Cap$48.79B
52W Range127.59 - 187.35
Beta0.27
Gross Margin45.44%
Oper. Margin11.80%
Profit Margin7.68%
Debt/Eq0.76
Current Ratio1.11
Quick Ratio0.64
Revenue 5Y8.00%

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
57/100
Financial Strength
Debt, cash, stability
50/100
Growth Potential
Revenue and expansion
38/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Positive free cash flow · 9.32Consistent free cash flow · 5/5Manageable debt level · 0.76Negative growth trend

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$159.00
Mean
$183.57
Median
$180.00
High
$210.00

Company Overview

IPO: 2/21/1973
Industry: Medical - Instruments & Supplies
P/B i: 1.66
Debt / Equity i: 0.76
Operating Margin: 11.80%
Net Margin: 7.68%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: 0.76
Current Ratio: 1.11
Quick Ratio: 0.64
Status: Moderate

Warnings

  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Byington Carrie L
Transaction: 08/06/2026
BUY
Change
+94
Price
Not reported
Filing
08/06/2026
Type
BUY
Huffines Robert Luther
Transaction: 08/06/2026
BUY
Change
+189
Price
Not reported
Filing
08/06/2026
Type
BUY
Feld Michael
Transaction: 07/27/2026
SELL
Change
-75
Price
$157.13
Filing
07/28/2026
Type
SELL